This is the authors' abstract. We don't add key points for this paper.
Infliximab was well tolerated and effective in a large cohort of patients with AS during a 24-week study period.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Heijde et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: